Back
Nuveen Municipal Credit Opportunities Fund Vs. Arcturus Therapeutics Holdings, Inc. Industry Stock Comparison
Sell
21
NMCO
Nuveen Municipal Credit Opportunities Fund
Last Price:
$10.64
Seasonality Move:
-0.01%
Sell
47
ARCT
Arcturus Therapeutics Holdings, Inc.
Last Price:
$8.02
Seasonality Move:
31.34%
Sell
21
Nuveen Municipal Credit Opportunities Fund (NMCO)
is a Sell
Is Nuveen Municipal Credit Opportunities Fund a Buy, Sell or Hold?
-
The current Nuveen Municipal Credit Opportunities Fund [NMCO] share price is $10.65. The Score for NMCO is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
-
NMCO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Arcturus Therapeutics Holdings, Inc. (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings, Inc. a Buy, Sell or Hold?
-
The current Arcturus Therapeutics Holdings, Inc. [ARCT] share price is $8.03. The Score for ARCT is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ARCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NMCO Stock Price Chart
What is Nuveen Municipal Credit Opportunities Fund's stock price today?
-
The Nuveen Municipal Credit Opportunities Fund share price today is $10.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NMCO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARCT Stock Price Chart
What is Arcturus Therapeutics Holdings, Inc.'s stock price today?
-
The Arcturus Therapeutics Holdings, Inc. share price today is $8.03Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARCT is experiencing slight buying pressure.
NMCO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.94 | Buy |
| Relative Strength Index (14 RSI): | 53.01 | Buy |
| Chaikin Money Flow: | 58328 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.49 - 10.77) | Buy |
| Bollinger Bands (100): | (10.43 - 10.81) | Buy |
ARCT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 62.43 | Buy |
| Chaikin Money Flow: | 180847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (6.67 - 7.77) | Buy |
| Bollinger Bands (100): | (6.54 - 7.8) | Buy |
NMCO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.51 | Buy |
| 20-day SMA: | 10.58 | Buy |
| 50-day SMA: | 10.68 | Sell |
| 200-day SMA: | 10.59 | Buy |
| 8-day EMA: | 10.57 | Buy |
| 20-day EMA: | 6.66 | Buy |
| 50-day EMA: | 3.47 | Buy |
| 200-day EMA: | 1 | Buy |
ARCT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.26 | Buy |
| 20-day SMA: | 7.05 | Buy |
| 50-day SMA: | 7.39 | Buy |
| 200-day SMA: | 11.49 | Sell |
| 8-day EMA: | 7.41 | Buy |
| 20-day EMA: | 7.24 | Buy |
| 50-day EMA: | 7.41 | Buy |
| 200-day EMA: | 10.47 | Sell |
Nuveen Municipal Credit Opportunities Fund Earnings Growth & NMCO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Arcturus Therapeutics Holdings, Inc. Earnings Growth & ARCT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.91 per share, and a decrease next year of $0.18 per share.
Nuveen Municipal Credit Opportunities Fund Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arcturus Therapeutics Holdings, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||